Explore a 28-minute webinar presented by Dr. Julien Camperi, a Scientist at Genentech, on the physicochemical and functional characterization of engineered Cas9 variants and CRISPR-Cas9 Ribonucleoprotein (RNP) complexes. Gain insights into the advances in gene-editing technology, particularly CRISPR-Cas systems, and their potential applications in therapeutic platforms for challenging disease areas. Learn about the efficient, targeted ex vivo engineering of different cell types and the powerful gene-editing tools used in therapeutic applications. Discover Dr. Camperi's expertise in analytical chemistry and his role in supporting analytical development processes in the T-Cell Therapy Engineering Group at Genentech. Delve into the cutting-edge research and development of CRISPR technology and its implications for future medical treatments.